The National Artificial Intelligence Application Pilot Base for the medical sector released phased achievements in Shanghai, presenting five core technological innovations and nine advanced smart medical applications. The initiative is aimed at supporting the high-quality development of China’s Artificial Intelligence plus healthcare sector and expanding intelligent medical services for the public.
Launched in 2025 and led by Zhongshan Hospital under the guidance of national and municipal authorities, the base has built an integrated pilot verification platform covering computing power, medical data, large models and clinical validation. The five breakthroughs target core medical industry challenges: a domestic computing power platform realizing “domestic models on domestic chips” with world-class performance; six vertical medical large models covering multiple clinical scenarios; a national demonstrative medical Artificial Intelligence data infrastructure; the globally leading MedBench 4.0 Chinese medical large model testing platform; and the transformation of lab technologies to clinical applications.
The nine flagship applications span clinical diagnosis, medical device research and development, Artificial Intelligence drug discovery and brain-computer interface. Key examples include Zhongshan Hospital’s “Guanxin” cardiovascular Artificial Intelligence agent, Renji Hospital’s urology Artificial Intelligence agent serving over 500,000 patients, and Huashan Hospital’s invasive brain-computer interface device, described as the world’s first to win China’s Class III medical device certificate.
Several systems have already entered broad clinical use. The hepatobiliary tumor Artificial Intelligence agent is used in 122 medical institutions serving over 1 million people, while the chest imaging one-scan multi-diagnosis agent has processed over 2.5 million cases in some 20 domestic hospitals, improving medical efficiency and supporting more precise medicine. According to the pilot base leadership, these deployments show that research outputs are beginning to translate into practical hospital workflows at scale.
The base also signed cooperation agreements with four Shanghai districts, eight research institutes, 28 hospitals and 20 tech enterprises to build a government-industry-university-research collaborative ecosystem. The next phase will focus on accelerating achievement transformation, strengthening a global medical Artificial Intelligence innovation hub, and contributing technological support to the Healthy China initiative.
